2004年12月1日

1分鐘閱讀

抗抑鬱藥：好藥還是好營銷？

關於青少年自殺的隱藏資料醜聞揭示了我們藥物審批系統的一個黑暗角落

作者：大衛·多布斯

加入我們的科學愛好者社群！

00

(Further Reading)

  • Suppression of Mosholder’s findings and testimony is documented by Anna Wilde Mathews’s article “In Debate over Antidepressants, FDA Weighed Risk of False Alarm Doubting Data on Suicide and Kids” in Wall Street Journal; May 25, 2004. Viewable at www.ahrp.org/infomail/04/05/25.html

  • Drug Company Experts Advised Staff to Withhold Data about SSRI Use in Children. Wayne Kondro in Canadian Medical Association Journal, Vol. 170; No. 5; March 2, 2004. Available online at www.cmaj.ca/cgi/content/full/170/5/783

More by David Dobbs
SA Mind Vol 14 Issue 5This article was originally published with the title “Perspectives: Antidepressants: Good Drugs or Good Marketing” in SA Mind Vol. 14 No. 5 (), p. 10
doi:10.1038/scientificamericanmind1204-10
View This Issue
© .